Home > PS Ratio > PIRAMAL PHARMA

PIRAMAL PHARMA
PS (Price/Sales) Ratio

The Current P/S Ratio of PIRAMAL PHARMA is 2.61.

Share Price ₹153.7May 08,2024
Market Cap ₹20,326.4 Cr
Sales-TTM₹7,782.4 CrTTM-Consolidated Results
Price/Sales2.61xCalculated as Market Cap/Sales
Explore Stock Analytics
COMMUNITY POLL
for PIRAMAL PHARMA
Please provide your vote to see the results
PIRAMAL PHARMA is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks

Definition & Calculation of PS (Price/Sales) ratio of PIRAMAL PHARMA

Price-to-Sales ratio, P/S Multiple, or P/S Ratio is an important valuation multiple that is defined as:

P/S = Market Capitalization / Sales

or, using per-share numbers:

P/S = Stock Price / Sales Per Share

Applying the above formula, P/S ratio of PIRAMAL PHARMA is calculated as :

Current Market Cap [ ₹20,326.4 Cr] as on May 08,2024

(/) Sales [ ₹7,782.4 Cr] based on TTM-Consolidated Results

(=) P/S Ratio [ 2.61x ]

P/S Ratio indicates 'the multiple of sales' investors are willing to pay to own one share of the company.

Thus, for PIRAMAL PHARMA , the investors are currently willing to pay '2.61 times sales' to own 1 share of the company.

PS Multiples are one of the most widely used valuation multiple in the industry.

P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.

You may also explore Price to Earnings ratio or Price to Book ratio of PIRAMAL PHARMA !

The chart below summarizes the trend in P/S Ratio of PIRAMAL PHARMA over the last five years.

Historical PS (Price/Sales) ratio chart of PIRAMAL PHARMA


PS Ratio Performance Analysis for PIRAMAL PHARMA

- PIRAMAL PHARMA 's latest p/e ratio is 2.61x.

- PIRAMAL PHARMA 's p/e ratio for fiscal years ending Mar2023 to Mar2021 averaged 0.38x.

- PIRAMAL PHARMA 's operated at median p/e ratio of 0x from fiscal years ending March 2018 to 2022.

- Looking back at the last 3 fiscal years, PIRAMAL PHARMA 's p/e ratio peaked in Mar2023 at 1.15x.

- PIRAMAL PHARMA 's p/e ratio hit its five-year low in Mar2022 of 0x.


How does PIRAMAL PHARMA 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Sales (Cr)PS RatioMarket Cap (Cr)
PIRAMAL PHARMA 7,782.42.6120,326.4
SUN PHARMACEUTICAL INDUSTRIES LTD47,444.67.69365,071.0
CIPLA LTD25,350.24.41111,808.0
DR REDDYS LABORATORIES LTD28,011.13.61101,035.0
ZYDUS LIFESCIENCES LTD19,024.25.32101,202.0
DIVIS LABORATORIES LTD7,492.813.92104,300.0
MANKIND PHARMA LTD9,946.38.7887,328.3
TORRENT PHARMACEUTICALS LTD10,474.08.3687,582.9
LUPIN LTD20,010.83.6873,640.1
AUROBINDO PHARMA LTD27,894.72.3966,562.6
ABBOTT INDIA LTD5,753.49.5855,132.6

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs PIRAMAL PHARMA 's P/S Ratio

Top 10 Industry PeersPS Ratio
Min industry PS 2.39x
Max industry PS 13.92x
Median industry PS 5.32x
Average industry PS 6.40x



You may also like the below Video Courses